Acorn Capital Advisors, LLC Puma Biotechnology, Inc. Transaction History
Acorn Capital Advisors, LLC
- $185 Billion
- Q4 2024
A detailed history of Acorn Capital Advisors, LLC transactions in Puma Biotechnology, Inc. stock. As of the latest transaction made, Acorn Capital Advisors, LLC holds 2,450,711 shares of PBYI stock, worth $7.01 Million. This represents 6.49% of its overall portfolio holdings.
Number of Shares
2,450,711Holding current value
$7.01 Million% of portfolio
6.49%Shares
1 transactions
Others Institutions Holding PBYI
# of Institutions
107Shares Held
32.2MCall Options Held
43.4KPut Options Held
3.7K-
Vanguard Group Inc Valley Forge, PA3.64MShares$10.4 Million0.0% of portfolio
-
Black Rock Inc. New York, NY3.57MShares$10.2 Million0.0% of portfolio
-
Frazier Life Sciences Management, L.P. Menlo Park, CA3.06MShares$8.76 Million0.42% of portfolio
-
Acadian Asset Management LLC Boston, MA1.97MShares$5.64 Million0.02% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny1.89MShares$5.42 Million0.0% of portfolio
About PUMA BIOTECHNOLOGY, INC.
- Ticker PBYI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 45,556,000
- Market Cap $130M
- Description
- Puma Biotechnology, Inc., a biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States and internationally. The company's drug candidates include PB272 neratinib (oral) for the patients with early stage HER2-overexpressed/amplified breast cancer; PB272 (neratinib, oral) for...